John Frater

Medicine & Life Sciences

1. Lymphoma 100%
2. Hematology 95%
3. B-Cell Chronic Lymphocytic Leukemia 83%
4. Acute Myeloid Leukemia 81%
5. Skin 73%
6. B-Lymphocytes 69%
7. Bone Marrow 69%
8. Leukemia 64%
9. Mantle-Cell Lymphoma 63%
10. Myeloid Sarcoma 62%
11. Cytogenetics 56%
12. Flow Cytometry 48%
13. Pandemics 45%
14. Neoplasms 45%
15. T-Cell Prolymphocytic Leukemia 43%
16. Hodgkin Disease 43%
17. Sinus Histiocytosis 41%
18. Tertiary Care Centers 39%
19. Myelodysplastic Syndromes 39%
20. Differential Diagnosis 38%
21. Biopsy 38%
22. T-Lymphocytes 37%
23. Fluorescence In Situ Hybridization 37%
24. Leukemia, Myelogenous, Chronic, BCR-ABL Positive 37%
25. Precursor Cell Lymphoblastic Leukemia-Lymphoma 35%
26. Molecular Pathology 35%
27. Lymphoproliferative Disorders 34%
28. Differentiation Antigens 34%
29. Lymphoma, Large B-Cell, Diffuse 33%
30. Malformations of Cortical Development 32%
31. Drug Resistant Epilepsy 32%
32. Cell Lineage 30%
33. Lymphocytosis 28%
34. Non-Hodgkin's Lymphoma 28%
35. Genes 28%
36. Lymph Nodes 28%
37. Chromosomes 27%
38. Central Nervous System 27%
39. Immunohistochemistry 27%
40. Interphase 27%
41. Trisomy 3q Chromosome 3 26%
42. Plasma Cells 26%
43. Hematologic Neoplasms 26%
44. Molecular Biology 26%
45. Reed-Sternberg Cells 25%
46. Histiocytic Sarcoma 25%
47. Cerebrospinal Fluid 24%
48. Histiocytosis 23%
49. Mast-Cell Leukemia 23%
50. midostaurin 23%